Inside the Gray Space of Digital Therapeutics
I recently attended the second DTxDM conference of the year, which was held on ...
What Do Facebook Ad Changes Mean for Medical Advertising?
Facebook is currently weathering crises on multiple fronts. Investor confidence is declining, user patience ...
Changing Roles in Pharma & Biotech Companies: CSMs Are the New CRAs
The rapidly evolving clinical trial paradigm is prompting altered expectations of the traditional Clinical ...
It’s Programmatic, Not Program Magic, Advertising
Something Eugene Lee, Executive Vice President, Managing Director at CMI, said earlier this month ...
Seize the Day
The multiple forces dramatically reshaping the healthcare industry show no sign of abating. Influence ...
Building a Better Patient Experience
Patients are people. That sounds simple enough, but sometimes pharma can be so focused ...
Caring for the Caregivers
Caregivers are significant players in the healthcare ecosystem and, for many individuals, a necessary ...
The Launch Trifecta
For a pharmaceutical marketer, few things carry the same level of professional gravitas as ...
Buy and Bill Specialty Drug Challenges
Prescribers face significant threats and challenges as they manage patients being treated with buy ...
Redefining Medical Necessity
As doctors, we are skilled in knowing what diagnostic tests are needed to determine ...
Collaboration or Collision?
The thermometer became a go-to medical device in the 18th Century. But, in the ...
Put the Patient Voice First
Biopharma aspires to integrate the voice of the patient into clinical and marketing programs. ...
